MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $9.35
0.02 (0.21%) Open Price: 9.12

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(10/17/25) $9.12
(10/21/25) $9.33
(10/21/25) (Qty.)2,713,347
(10/17/25) $8.80
(10/17/25) $9.27
(09/28/25) $5.95
(10/12/25) $10.95
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing